Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Personalised medicine differs from precision medicine

Published: 11 Dec 2017

Views: 2109

Rating:

Save

Prof Christine Chomienne - INCa, Paris, France

Christine Chomienne talks to ecancer at EAPM 2017 in Belfast.

She discussed the Athena SWAN act which helps women in science with their career and mentorship.

She also outlines her two main goals for personalised medicine, and how this differs from precision medicine.

One large aspect of this is how to combine all the genomic data across Europe.

Related Videos

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic...

Prof Eileen M O’Reilly - Memorial Sloan Kettering Cancer Center, New York City...

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer ( Prof Eileen M O’Reilly - Memorial Sloan Kettering Cancer Center, New York City, USA )

Choosing Wisely in pathology

Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

Choosing Wisely in pathology ( Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )

Choosing Wisely in radiology Tanzania

Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

Choosing Wisely in radiology Tanzania ( Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+...

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )

Advocacy that impacts patients outcomes in Africa - challenges and opportunities

Franklin Mtei - Patient Advocate, Inspire2Live

Advocacy that impacts patients outcomes in Africa - challenges and opportunities ( Franklin Mtei - Patient Advocate, Inspire2Live )

Global adoption of single-shot targeted IORT for breast cancer

Dr Jayant Vaidya - University College London, London, UK

Global adoption of single-shot targeted IORT for breast cancer ( Dr Jayant Vaidya - University College London, London, UK )

Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk...

Dr Eunice Wang - Roswell Park Comprehensive Cancer Center, New York, USA

Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML ( Dr Eunice Wang - Roswell Park Comprehensive Cancer Center, New York, USA )

Redefining cancer research priorities in the emerging context of the COVID-19...

Prof Richard Sullivan - King's College London, London, UK

Redefining cancer research priorities in the emerging context of the COVID-19 pandemic ( Prof Richard Sullivan - King's College London, London, UK )

More from ecancer